Bullish View on Spruce Biosciences; Kroger Posts Mixed Results
- September 08th, 2023
- 436 views
Spruce Biosciences, Inc. (Nasdaq: SPRB), a pharmaceutical company, was upgraded from Market Perform to Outperform by SVB Leerink, accompanied by a revised price target increase from $3 to $9.
Given that $SPRB closed at $2.23 on Thursday, this adjusted price target suggests a potential upside of $6.77 per share or approximately 303.13%, based on the assessment by the investment firm.
In other news, The Kroger Co. (NYSE: KR), a major retail corporation, reported second-quarter 2023 earnings of $0.96 per share, surpassing the consensus EPS estimate of $0.91. The company's quarterly sales amounted to $33.85 billion, slightly below analysts' projected revenue of $34.13 billion for the period.
$KR was trading at $44.54 in pre-market, down $0.99 (-2.17%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
NJCP Football League Provides Development and Opportunity for Athletes Pursuing the Next Level
March 20th, 2026March 19th, 2026How High School Graduates Can Kickstart Their Football Career
March 18th, 2026
Member Login